capable

FDA approves first drug capable of delaying the onset of type 1 diabetes

FDA approves first drug capable of delaying the onset of type 1 diabetes

For immediate release: November 17, 2022 Today, the United States Food and Drug Administration approved Tzield (teplizumab-mzwv) injection for delaying the onset of type 1 diabetes mellitus stage 3 in adults and pediatric patients 8 years of age and older who currently have stage 2 type 1 diabetes. “Today’s approval of a first-in-class therapy adds …

FDA approves first drug capable of delaying the onset of type 1 diabetes Read More »